TOKYO — Osaka University professor Shimon Sakaguchi, who shared this year’s Nobel Prize in physiology or medicine for the discovery of regulatory T-cells, told Nikkei on Friday that he hopes to make advances in applications in “various fields of cancer treatment.”

Read more here

Previous
Clarivate Repeats Success in Nobel Prize Predictions with 6 New Laureates Identified by Citation Laureates Program
Next
Viewpoint: Japan is on the cusp of a tech commercialisation revolution